98 related articles for article (PubMed ID: 12814971)
1. Metabolism-based inactivation of neuronal nitric-oxide synthase by components of cigarette and cigarette smoke.
Demady DR; Lowe ER; Everett AC; Billecke SS; Kamada Y; Dunbar AY; Osawa Y
Drug Metab Dispos; 2003 Jul; 31(7):932-7. PubMed ID: 12814971
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent inhibition and tetrahydrobiopterin depletion of endothelial nitric-oxide synthase caused by cigarettes.
Lowe ER; Everett AC; Lee AJ; Lau M; Dunbar AY; Berka V; Tsai AL; Osawa Y
Drug Metab Dispos; 2005 Jan; 33(1):131-8. PubMed ID: 15470159
[TBL] [Abstract][Full Text] [Related]
3. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the heme prosthetic group of neuronal nitric-oxide synthase during inactivation by N(G)-amino-L-arginine in vitro and in vivo.
Vuletich JL; Lowe ER; Jianmongkol S; Kamada Y; Kent UM; Bender AT; Demady DR; Hollenberg PF; Osawa Y
Mol Pharmacol; 2002 Jul; 62(1):110-8. PubMed ID: 12065761
[TBL] [Abstract][Full Text] [Related]
5. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase.
Noguchi S; Jianmongkol S; Bender AT; Kamada Y; Demady DR; Osawa Y
J Biol Chem; 2000 Jan; 275(4):2376-80. PubMed ID: 10644688
[TBL] [Abstract][Full Text] [Related]
7. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrobiopterin protects against guanabenz-mediated inhibition of neuronal nitric-oxide synthase in vitro and in vivo.
Dunbar AY; Jenkins GJ; Jianmongkol S; Nakatsuka M; Lowe ER; Lau M; Osawa Y
Drug Metab Dispos; 2006 Sep; 34(9):1448-56. PubMed ID: 16738031
[TBL] [Abstract][Full Text] [Related]
9. Ni(2+), a double-acting inhibitor of neuronal nitric oxide synthase interfering with L-arginine binding and Ca(2+)/calmodulin-dependent enzyme activation.
Palumbo A; Astarita G; Picardo M; d'Ischia M
Biochem Biophys Res Commun; 2001 Jul; 285(1):142-6. PubMed ID: 11437384
[TBL] [Abstract][Full Text] [Related]
10. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the successive reaction catalyzed by rat neuronal nitric oxide synthase.
Iwanaga T; Yamazaki T; Kominami S
Biochemistry; 2000 Dec; 39(49):15150-5. PubMed ID: 11106494
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination and degradation of neuronal nitric-oxide synthase in vitro: dimer stabilization protects the enzyme from proteolysis.
Dunbar AY; Kamada Y; Jenkins GJ; Lowe ER; Billecke SS; Osawa Y
Mol Pharmacol; 2004 Oct; 66(4):964-9. PubMed ID: 15235101
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring neuronal NO-synthase inactivators found in Nicotiana tabacum (Solanaceae) and other plants.
Lowe ER; Everett AC; Lau M; Dunbar AY; Michener D; Osawa Y
Phytomedicine; 2007 May; 14(5):344-52. PubMed ID: 17084601
[TBL] [Abstract][Full Text] [Related]
14. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
Gorren AC; Schrammel A; Schmidt K; Mayer B
Biochemistry; 1997 Apr; 36(14):4360-6. PubMed ID: 9100033
[TBL] [Abstract][Full Text] [Related]
15. Activation and inactivation of neuronal nitric oxide synthase: characterization of Ca(2+)-dependent [125I]Calmodulin binding.
Weissman BA; Jones CL; Liu Q; Gross SS
Eur J Pharmacol; 2002 Jan; 435(1):9-18. PubMed ID: 11790373
[TBL] [Abstract][Full Text] [Related]
16. Naphthoquinones and bioactive compounds from tobacco as modulators of neuronal nitric oxide synthase activity.
Venkatakrishnan P; Gairola CG; Castagnoli N; Miller RT
Phytother Res; 2009 Dec; 23(12):1663-72. PubMed ID: 19367663
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress.
Zhang WZ; Venardos K; Chin-Dusting J; Kaye DM
Hypertension; 2006 Aug; 48(2):278-85. PubMed ID: 16801489
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of aminoguanidine, diaminoguanidine, and NG-amino-L-arginine by neuronal NO-synthase and covalent alteration of the heme prosthetic group.
Lee AJ; Noon KR; Jianmongkol S; Lau M; Jenkins GJ; Osawa Y
Chem Res Toxicol; 2005 Dec; 18(12):1927-33. PubMed ID: 16359183
[TBL] [Abstract][Full Text] [Related]
19. The protein inhibitor of neuronal nitric oxide synthase (PIN): characterization of its action on pure nitric oxide synthases.
Hemmens B; Woschitz S; Pitters E; Klösch B; Völker C; Schmidt K; Mayer B
FEBS Lett; 1998 Jul; 430(3):397-400. PubMed ID: 9688579
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
